Welcome to the CCO Site

Thank you for your interest in CCO content. As a guest, please complete the following information fields. These data help ensure our continued delivery of impactful education. 

Become a member (or login)? Member benefits include accreditation certificates, downloadable slides, and decision support tools.

Submit

Antiviral Agents for Nonhospitalized Patients With COVID-19

Hear expert insights on the use of IV and oral antiviral agents for the treatment of nonhospitalized patients with COVID-19.
Sharon R. Lewin, AO, FRACP, PhD, FAHMS
Released: January 6, 2022

Information on this Educational Activity

Faculty

Sharon R. Lewin, AO, FRACP, PhD, FAHMS

Director, The Peter Doherty Institute for Infection and Immunity
Professor of Infectious Diseases
University of Melbourne
Consultant Infectious Diseases Physician
Alfred Hospital and Royal Melbourne Hospital
Melbourne, Australia

Sharon R. Lewin, AO, FRACP, PhD, FAAHMS, has disclosed that she has received consulting fees from AbbVie, Gilead Sciences, and ViiV Healthcare; funds for research support from Leidos; and other financial or material support from Gilead Sciences, Merck, and ViiV Healthcare.

Program Medium

This program has been made available online.

Related Content

Dr Lilian Abbo reviews the current landscape of ExPEC vaccines and their possible role in reducing antibiotic resistance, from Clinical Care Options (CCO)

Lilian Abbo Headshot Lilian Abbo, MD, FIDSA Released: October 6, 2022

Expert summaries of COVID-19 testing, risk stratification, treatment options, and long COVID, from Clinical Care Options (CCO), Practicing Clinicians Exchange (PCE), and ProCE.

Jason E. Farley, PhD, MPH, ANP-BC, FAAN, FAANP, AACRN Renslow Sherer, MD person default Trinh P. Vu, PharmD, BCIDP Released: October 6, 2022

This downloadable PDF reviews COVID-19 diagnostic testing and risk stratification of patients who test positive, from Clinical Care Options (CCO), PCE (Practicing Clinicians Exchange), and ProCE

Renslow Sherer, MD Released: October 3, 2022

Trinh P. Vu, PharmD, BCIDP: management of COVID-19 in the outpatient setting using oral antiviral agents, from Clinical Care Options (CCO)

person default Trinh P. Vu, PharmD, BCIDP Released: September 28, 2022
Provided by Clinical Care Options, LLC

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Supported by educational grants from
Gilead Sciences, Inc.
Janssen Therapeutics, Division of Janssen Products, LP
Merck Sharp & Dohme Corp.

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Cookie Settings